Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

HealthTech approach

HealthTech approach

Advice programme

Area of interest

Showing 1301 to 1350 of 2570

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Vandetanib for treating medullary thyroid cancerTA550
Decitabine for untreated acute myeloid leukaemia (terminated appraisal)TA548
Denosumab for preventing skeletal-related events in multiple myeloma (terminated appraisal)TA549
Chronic obstructive pulmonary disease (acute exacerbation): antimicrobial prescribingNG114
Post-traumatic stress disorderNG116
Transcranial MRI-guided focused ultrasound thalamotomy for neuropathic painHTG491
Percutaneous insertion of a temporary heart pump for left ventricular haemodynamic support in high-risk percutaneous coronary interventionsHTG492
Tofacitinib for moderately to severely active ulcerative colitisTA547
Urinary tract infection (catheter-associated): antimicrobial prescribingNG113
Padeliporfin for untreated localised prostate cancerTA546
Subcutaneous automated low-flow pump implantation for refractory ascites caused by cirrhosisHTG490
Gemtuzumab ozogamicin for untreated acute myeloid leukaemiaTA545
Selective internal radiation therapy for unresectable primary intrahepatic cholangiocarcinomaHTG489
Pyelonephritis (acute): antimicrobial prescribingNG111
Urinary tract infection (lower): antimicrobial prescribingNG109
Prostatitis (acute): antimicrobial prescribingNG110
Servo-n with Neurally Adjusted Ventilatory Assist (NAVA) for babies and childrenMIB163
Romiplostim for the treatment of chronic immune thrombocytopeniaTA221
Eltrombopag for treating chronic immune thrombocytopeniaTA293
Myeloma: diagnosis and managementNG35
Dabrafenib with trametinib for adjuvant treatment of resected BRAF V600 mutation-positive melanomaTA544
Lyme diseaseNG95
Renal replacement therapy services for adultsQS72
Cabozantinib for untreated advanced renal cell carcinomaTA542
Tofacitinib for treating active psoriatic arthritis after inadequate response to DMARDsTA543
Renal replacement therapy and conservative managementNG107
Decision-making and mental capacityNG108
myAIRVO2 for the treatment of chronic obstructive pulmonary diseaseMIB161
E‑vita open plus for treating complex aneurysms and dissections of the thoracic aortaHTG326
OxyMask for delivering oxygen therapyMIB160
Eating disordersQS175
AsthmaQS25
Intravesical microwave hyperthermia and chemotherapy for non-muscle-invasive bladder cancerHTG487
Inotuzumab ozogamicin for treating relapsed or refractory B-cell acute lymphoblastic leukaemiaTA541
The Vest for delivering high-frequency chest wall oscillation in people with complex neurological needsMIB159
Preventing suicide in community and custodial settingsNG105
Emergency and acute medical care in over 16sQS174
Superior rectal artery embolisation for haemorrhoidsHTG485
Lutetium (177Lu) oxodotreotide for treating unresectable or metastatic neuroendocrine tumoursTA539
Neon EEG electrode for EEG monitoring in newbornsMIB155
AlignRT in breast cancer radiotherapyMIB157
Sutureless aortic valve replacement for aortic stenosisHTG483
Dinutuximab beta for treating neuroblastomaTA538
Flu vaccination: increasing uptakeNG103
Transurethral water vapour ablation for lower urinary tract symptoms caused by benign prostatic hyperplasiaHTG482
Intermediate care including reablementQS173
Lenvatinib and sorafenib for treating differentiated thyroid cancer after radioactive iodineTA535
Alectinib for untreated ALK-positive advanced non-small-cell lung cancerTA536
Ixekizumab for treating active psoriatic arthritis after inadequate response to DMARDsTA537
EndometriosisQS172

Results per page

  1. 10
  2. 25
  3. 50
  4. All